Francis A, Harhay MN, Ong ACM, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:473–85.

Article  PubMed  Google Scholar 

Anders HJ, Huber TB, Isermann B, et al. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14(6):361–77.

Article  CAS  PubMed  Google Scholar 

Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73–81.

Article  CAS  PubMed  Google Scholar 

Matsushita K, Ballew SH, Wang AY, et al. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18(11):696–707.

Article  PubMed  Google Scholar 

Jha V, Al-Ghamdi SMG, Li G, et al. Global economic burden associated with chronic kidney disease: a pragmatic review of medical costs for the inside CKD research programme. Adv Ther. 2023;40(10):4405–20.

Article  PubMed  PubMed Central  Google Scholar 

Farrimond B, Agathangelou G, Gofman L, et al. Kidney research UK. Kidney disease: a UK public health emergency. The health economics of kidney disease to 2033. 2023. https://www.kidneyresearchuk.org/wp-content/uploads/2023/06/Economics-of-Kidney-Disease-full-report_accessible.pdf. Accessed 30 Apr 2025.

Maheswaran R, Payne N, Meechan D, et al. Socioeconomic deprivation, travel distance, and renal replacement therapy in the Trent Region, United Kingdom 2000: an ecological study. J Epidemiol Community Health. 2003;57(7):523–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80(1):17–28.

Article  PubMed  Google Scholar 

Sud M, Tangri N, Levin A, et al. CKD stage at nephrology referral and factors influencing the risks of ESRD and death. Am J Kidney Dis. 2014;63(6):928–36.

Article  PubMed  Google Scholar 

Thompson S, James M, Wiebe N, et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26(10):2504–11.

Article  PubMed  PubMed Central  Google Scholar 

Glovaci D, Fan W, Wong ND. Epidemiology of diabetes mellitus and cardiovascular disease. Curr Cardiol Rep. 2019;21(4):21.

Article  PubMed  Google Scholar 

Marassi M, Fadini GP. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023;22(1):195.

Article  PubMed  PubMed Central  Google Scholar 

British Heart Foundation. Scotland cardiovascular disease factsheet. 2023. https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-cvd-statistics-scotland-factsheet.pdf. Accessed 30 Apr 2025.

Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.

Article  PubMed  Google Scholar 

Watt G. The inverse care law revisited: a continuing blot on the record of the National Health Service. Br J Gen Pract. 2018;68(677):562–3.

Article  PubMed  PubMed Central  Google Scholar 

Hart JT. The inverse care law. Lancet. 1971;1(7696):405–12.

Article  CAS  PubMed  Google Scholar 

Doran N, Fox F, Rodham K, et al. Lost to the NHS: a mixed methods study of why GPs leave practice early in England. Br J Gen Pract. 2016;66(643):e128–35.

Article  PubMed  PubMed Central  Google Scholar 

Parisi R, Lau Y-S, Bower P, et al. Predictors and population health outcomes of persistent high GP turnover in English general practices: a retrospective observational study. BMJ Qual Saf. 2023;32(7):394–403.

Article  PubMed  PubMed Central  Google Scholar 

Bhatnagar P, Wickramasinghe K, Williams J, et al. The epidemiology of cardiovascular disease in the UK 2014. Heart. 2015;101(15):1182–9.

Article  CAS  PubMed  Google Scholar 

Calderwood C. Realising realistic medicine: Chief Medical Officer's annual report 2015–16. 2017. https://www.gov.scot/publications/chief-medical-officer-scotland-annual-report-2015-16-realising-realistic-9781786526731/. Accessed 30 Apr 2025.

Damarell RA, Morgan DD, Tieman JJ. General practitioner strategies for managing patients with multimorbidity: a systematic review and thematic synthesis of qualitative research. BMC Fam Pract. 2020;21(1):131.

Article  PubMed  PubMed Central  Google Scholar 

Tan EC, Stewart K, Elliott RA, et al. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Soc Adm Pharm. 2014;10(4):608–22.

Article  Google Scholar 

Hunt V, Anderson D, Lowrie R, et al. A non-randomised controlled pilot study of clinical pharmacist collaborative intervention for community dwelling patients with COPD. NPJ Prim Care Respir Med. 2018;28(1):38.

Article  PubMed  PubMed Central  Google Scholar 

Johnson CF, Maskrey M, Macbride-Stewart S, et al. New ways of working releasing general practitioner capacity with pharmacy prescribing support: a cost-consequence analysis. Fam Pract. 2022;39(4):648–55.

Article  PubMed  Google Scholar 

Clarke G. Pharmaceutical Society of Australia (PSA) release pharmacist prescribing position statement. 2024. https://www.psa.org.au/psa-release-pharmacist-prescribing-position-statement/#:~:text=PSA%20National%20President%20Associate%20Professor,to%20medicines%2C%20not%20limit%20it.&text=%E2%80%9CPharmacists%20should%20not%20be%20prevented,within%20their%20scope%20of%20practice. Accessed 30 Apr 2025.

Norman K, Cassim S, Papa V, et al. “Prescribing for the whole person”: a qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand. BMC Health Serv Res. 2023;23(1):1058.

Article  PubMed  PubMed Central  Google Scholar 

The Scottish Government. The 2018 general medical services contract in Scotland. 2017. https://www.gov.scot/binaries/content/documents/govscot/publications/advice-and-guidance/2017/11/2018-gms-contract-scotland/documents/00527530-pdf/00527530-pdf/govscot%3Adocument/00527530.pdf. Accessed 30 Apr 2025.

NHS England. More than 400 pharmacists to be recruited to GP surgeries by next year. 2015. https://www.england.nhs.uk/2015/11/pharmacists-recruited/. Accessed 30 Apr 2025.

Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348: g1687.

Article  PubMed  Google Scholar 

Cheung AK, Chang TI, Cushman WC, et al. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):S1–87.

Article  Google Scholar 

Sign 154. Pharmacological management of glycaemic control in people with type 2 diabetes. 2017. https://www.sign.ac.uk/media/1090/sign154.pdf. Accessed 30 Apr 2025.

NICE 203—chronic kidney disease: assessment and management. 2021. https://www.nice.org.uk/guidance/ng203/resources/chronic-kidney-disease-assessment-and-management-pdf-66143713055173. Accessed 30 Apr 2025.

McQuarrie E. Chronic kidney disease, adult: diagnosis and management (1087). 2023. https://rightdecisions.scot.nhs.uk/media/2735/1087-adult-chronic-kidney-disease.pdf. Accessed 30 Apr 2025.

Byrne J. Coronary heart disease and stroke, primary and secondary prevention guideline (cholesterol). 2022. https://rightdecisions.scot.nhs.uk/ggc-clinical-guideline-platform/endocrine/co-morbidities/coronary-heart-disease-and-stroke-primary-and-secondary-prevention-cholesterol-181/. Accessed 30 Apr 2025.

Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88.

Article  PubMed  Google Scholar 

Scottish Government. Scottish Government Polypharmacy Model of Care Group. Polypharmacy guidance, realistic prescribing. 3rd ed. 2018. https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/04/Polypharmacy-Guidance-2018.pdf. Accessed 30 Apr 2025.

Polypharmacy review in adults living with moderate to severe frailty. 2022. https://rightdecisions.scot.nhs.uk/media/2276/polypharmacy-review.pdf. Accessed 30 Apr 2025.

Quality Prescribing Strategy for Type 2 Diabetes Mellitus. A guide for improvement 2024–2027. 2024. https://www.gov.scot/binaries/content/documents/govscot/publications/advice-and-guidance/2024/01/quality-prescribing-strategy-type-2-diabetes-mellitus-guide-improvement-2024-2027/documents/quality-prescribing-strategy-type-2-diabetes-mellitus-guide-improvement-2024-2027/quality-prescribing-strategy-type-2-diabetes-mellitus-guide-improvement-2024-2027/govscot%3Adocument/quality-prescribing-strategy-type-2-diabetes-mellitus-guide-improvement-2024-2027.pdf. Accessed 30 Apr 2025.

Kidney Care UK. Patient information booklets. https://kidneycareuk.org/get-support/free-resources/patient-information-booklets/. Accessed 30 Apr 2025.

Triantafylidis LK, Hawley CE, Perry LP, et al. The role of deprescribing in older adults with chronic kidney disease. Drugs Aging. 2018;35(11):973–84.

Article  PubMed  PubMed Central  Google Scholar 

Brady A. Hypertension management, heart managed clinical network. Greater Glasgow and Clyde clinical guidelines 2020. https://clinicalguidelines.nhsggc.org.uk/media/1964/hypertension-management-heart-mcn.pdf. Accessed 30 Apr 2025.

So BH, Methven S, Hair MD, et al. Socio-economic status influences chronic kidney disease prevalence in primary care: a community-based cross-sectional analysis. Nephrol Dial Transplant. 2015;30(6):1010–7.

Article  PubMed